These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 15406)
21. [Progress on the study of neurochemical mechanisms of learning and memory]. Liu YQ; Gu JF Sheng Li Ke Xue Jin Zhan; 1998 Jul; 29(3):203-8. PubMed ID: 12501636 [TBL] [Abstract][Full Text] [Related]
23. Molecular and cellular interactions underlying higher brain functions. Proceedings of the 9th meeting of the International Neurobiology Society, (France), on September 1-4, 1981. Prog Brain Res; 1983; 58():1-483. PubMed ID: 6138806 [No Abstract] [Full Text] [Related]
24. Neuropeptides in behavior and psychiatric syndromes: an overview. Barchas JD; Elliott GR Res Publ Assoc Res Nerv Ment Dis; 1986; 64():287-307. PubMed ID: 2873638 [No Abstract] [Full Text] [Related]
25. Regulation of glycogenolysis by neurotransmitters in the central nervous system. Magistretti PJ Diabete Metab; 1988; 14(3):237-46. PubMed ID: 2900788 [TBL] [Abstract][Full Text] [Related]
26. Neuropeptides: peripheral and central messengers of the brain. Joosse J Prog Clin Biol Res; 1986; 205():13-32. PubMed ID: 2869501 [No Abstract] [Full Text] [Related]
27. [Acupuncture analgesia: its neuronal pathways and relevant neurotransmitters]. Han JS Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):294-300. PubMed ID: 6152707 [No Abstract] [Full Text] [Related]
28. Protons as intercellular messengers. Kim JS; Zhen M Cell; 2008 Jan; 132(1):21-2. PubMed ID: 18191215 [TBL] [Abstract][Full Text] [Related]
30. [Structural and functional organization of the cerebral dopaminergic system]. Barishpolets VV; Fedotova IuO; Sapronov NS Eksp Klin Farmakol; 2009; 72(3):44-9. PubMed ID: 19642593 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms and models of REM sleep control. McCarley RW Arch Ital Biol; 2004 Jul; 142(4):429-67. PubMed ID: 15493547 [TBL] [Abstract][Full Text] [Related]
32. [Vasopressin as a neurotransmitter and neuromodulator]. Kosekova G; Paneva R; Sirakov L Eksp Med Morfol; 1993; 31(1-2):35-41. PubMed ID: 7903072 [TBL] [Abstract][Full Text] [Related]
33. Neurotransmitters and diseases of the brain. Perry EK Br J Hosp Med; 1991 Feb; 45(2):73-83. PubMed ID: 1673358 [TBL] [Abstract][Full Text] [Related]
34. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Levite M Curr Opin Pharmacol; 2008 Aug; 8(4):460-71. PubMed ID: 18579442 [TBL] [Abstract][Full Text] [Related]
35. Aging, plasticity and environmental enrichment: structural changes and neurotransmitter dynamics in several areas of the brain. Mora F; Segovia G; del Arco A Brain Res Rev; 2007 Aug; 55(1):78-88. PubMed ID: 17561265 [TBL] [Abstract][Full Text] [Related]
36. "First step" negative feedback accounts for inhibition of fast neurotransmitter release. Khanin R; Parnas H; Segel L J Theor Biol; 1997 Oct; 188(3):261-76. PubMed ID: 9344731 [TBL] [Abstract][Full Text] [Related]
38. Third Soviet-Italian Joint Meeting on Neurotransmitters and Brain Function Capo Boi, Sardinia, June 1979. Pharmacol Res Commun; 1980 Mar; 12(3):225-92. PubMed ID: 6104823 [No Abstract] [Full Text] [Related]